FindTrial
Sign In

DOUBLE BLIND RANDOMISED CONTROLLED TRIAL COMPARING MISOPROSTOL AND OXYTOCIN IN MANAGEMENT OF THIRD STAGE OF LABOUR IN A NIGERIAN HOSPITAL

DOUBLE BLIND RANDOMISED CONTROLLED TRIAL COMPARING MISOPROSTOL AND OXYTOCIN IN MANAGEMENT OF THIRD STAGE OF LABOUR IN A NIGERIAN HOSPITAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201407000825227
Enrollment
Unknown
Registered
2014-05-13
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PPH

Interventions

Oral Misoprostol
intramuscular oxytocin

Sponsors

Dr. Musa Abdulkarim Omoyine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: singleton pregnancy term pregnancy spontaneous active phase labour spontaneous vaginal delivery

Exclusion criteria

Exclusion criteria: grandmultiparity multiple pregnancies uterine fibroid co-existing with pregnancy polyhydramnios preeclampsia/eclampsia, hypertension cardiac disease asthma placenta praevia abruption placenta previous postpartum haemorrhage patients who had oxytocin and/or misoprostol in labour other than in the third stage of labour patients being planned for instrumental vaginal delivery patients with prolonged rupture of membrane patients with anaemia (Hb < 10g/dl)

Design outcomes

Primary

MeasureTime frame
Postpartum blood loss;Postpartum blood loss—

Secondary

MeasureTime frame
change in maternal haemoglobin concentration ;Duration of third stage of labour ;Use of additional uterotonics;Side effects such as shivering, vomiting, diarrhoea, pyexia(>38degree celsius)0—

Countries

Nigeria

Contacts

Public ContactAbdulkarim Omoyine

Consultant

doctormusaak2004@yahoo.com+2348062872400

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Mar 5, 2026